The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The performance of the two‐stage analysis of two‐treatment, two‐period crossover trials
Abstract
In the two‐treatment, two‐period crossover trial, patients are randomly allocated either to one group that receives treatment A followed by treatment B, or to another group that receives the treatments in the reverse order. Grizzle first proposed a two‐stage procedure for analysing the data from such a trial. This paper examines the long‐run sampling properties of this procedure, in terms of mean square error of point estimates, coverage probability of confidence intervals and actual significance level of hypothesis tests for the differences between the effects of the two treatments. The advantages of incorporating baseline observations into the analysis are also explored. Because the preliminary test for carryover is highly correlated with the analysis of data from the first period only, actual significance levels are higher than nominal levels even when there is no differential carryover. When carryover is present, the nominal level very seriously understates the actual level, and this becomes even worse when baseline observations are ignored. Increasing sample size only exacerbates the problem since this adverse behaviour then occurs at smaller values of the carryover effect. It is concluded that the two‐stage analysis is too potentially misleading to be of practical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395
The Two-Period Change-Over Design and Its Use in Clinical Trials
Grizzle, J. E. (1965) · Biometrics · doi:10.2307/2528104 · Cited by 784
The Crossover Experiment for Clinical Trials
Brown, B. W. (1980) · Biometrics · doi:10.2307/2530496 · Cited by 372
The Two-Period Crossover Trial
Armitage, P., & Hills, M. (1982) · The Statistician · doi:10.2307/2987883 · Cited by 175
Carryover and the Two-Period Crossover Clinical Trial
Willan, A. R., & Pater, J. L. (1986) · Biometrics · doi:10.2307/2531209 · Cited by 99
The analysis of data from 2 × 2 cross‐over trials with baseline measurements
Kenward, M. G., & Jones, B. C. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060806 · Cited by 81
Using the Maximum Test Statistic in the Two-Period Crossover Clinical Trial
Willan, A. R. (1988) · Biometrics · doi:10.2307/2531908 · Cited by 25
The Desirability of Adjusting for Residual Effects in a Crossover Design
Abeyasekera, S., & Curnow, R. N. (1984) · Biometrics · doi:10.2307/2531157 · Cited by 21
Testing Crossover Studies for Carryover Effects
Cleophas, T. J. (1989) · Angiology · doi:10.1177/0003319789040004087 · Cited by 14
Research works printed but not linked: 2
- 10.2307/2529243 · doi:10.2307/2529243
- Grieve A. P., 1985, A Bayesian analysis of the two‐period crossover clinical trial, Biometrics, 42, 593
Cited by
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
15 Design and Analysis of Cross-Over Trials
Kenward, M. G., & Jones, B. (2007) · Handbook of Statistics · doi:10.1016/s0169-7161(07)27015-4 · Cited by 871
CONSORT 2010 statement: extension to randomised crossover trials
Dwan, K., Li, T., Altman, D. G., & Elbourne, D. (2019) · BMJ · doi:10.1136/bmj.l4378 · Cited by 785
Metadata
- Authors
- Freeman, P. R.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 1989-12
- Volume
- 8
- Issue
- 12
- Pages
- 1421-1432
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2002288054
- Cited by
- 272
- References
- 9
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.